Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease

1 Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan, 2 Department of Health and Environmental Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan, 3 Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan, 4 Statistical Analysis Section, Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan, 5 Graduate School of Regional Innovation Studies, Mie University, Tsu, Japan, 6 Department of Preventive Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 7 Congenital Anomaly Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan, 8 Department of Neurosurgery, Takayama Red Cross Hospital, Gifu, Japan, 9 Department of Genome Science, School of Dentistry, Aichi Gakuin University, Nagoya, Japan, 10 Department of Internal Medicine, School of Dentistry, Aichi Gakuin University, Nagoya, Japan, 11 Department of Medical Biochemistry, Kurume University School of Medicine, Fukuoka, Japan, 12 Department of Cardiology, Fujita Health University, Banbuntane Hotokukai Hospital, Nagoya, Japan

[1]  T. Funahashi,et al.  Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. , 2007, Journal of atherosclerosis and thrombosis.

[2]  Gao T. Wang,et al.  RNF213 Rare Variants in an Ethnically Diverse Population With Moyamoya Disease , 2014, Stroke.

[3]  A. Folsom,et al.  Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA. , 2000, International journal of epidemiology.

[4]  Eloi Marijon,et al.  State-of-the-art Paper Prevalences, Patterns, and the Potential of Early Disease Detection , 2022 .

[5]  Y. Kuroiwa,et al.  Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease , 2012, Neurology.

[6]  K. Nakao,et al.  Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. , 2013, Biochemical and biophysical research communications.

[7]  Sung-il Cho,et al.  Time Trend and Age-Period-Cohort Effects on Acute Myocardial Infarction Mortality in Korean Adults from 1988 to 2007 , 2011, Journal of Korean medical science.

[8]  C. Antoniades,et al.  Wnt signaling in cardiovascular physiology , 2012, Trends in Endocrinology & Metabolism.

[9]  Hiroyuki Asano,et al.  Relation of a common variant of the adiponectin gene to serum adiponectin concentration and metabolic traits in an aged Japanese population , 2011, European Journal of Human Genetics.

[10]  A Takaku,et al.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. , 1969, Archives of neurology.

[11]  Kouichi Ozaki,et al.  Molecular genetics of coronary artery disease , 2015, Journal of Human Genetics.

[12]  A. Hata,et al.  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene , 2011, Journal of Human Genetics.

[13]  D Kromhout,et al.  Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. , 1995, JAMA.

[14]  A. Koizumi,et al.  Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population , 2016, Environmental Health and Preventive Medicine.

[15]  J. Hoseki,et al.  Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state , 2014, Scientific Reports.

[16]  M. Guan,et al.  Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population , 2012, PloS one.

[17]  Y. Zhang,et al.  Body Mass Index, High-Sensitivity C-Reactive Protein and Mortality in Chinese with Coronary Artery Disease , 2015, PloS one.

[18]  K. Nozaki,et al.  Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  D. Taura,et al.  Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo , 2015, Journal of the American Heart Association.

[20]  O. Delaneau,et al.  Supplementary Information for ‘ Improved whole chromosome phasing for disease and population genetic studies ’ , 2012 .

[21]  K. Tatara,et al.  Heart disease deaths in a Japanese urban area evaluated by clinical and police records. , 1994, Circulation.

[22]  Robert K. Yu,et al.  Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. , 2009, American journal of human genetics.

[23]  S. Nanayakkara,et al.  P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure , 2013, Environmental Health and Preventive Medicine.

[24]  Wenhua Zhao,et al.  Emergence of chronic non-communicable diseases in China , 2008, The Lancet.

[25]  A. Fujiyama,et al.  Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development , 2011, PloS one.

[26]  浅野 展行.  Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population , 2010 .

[27]  K. Yamagishi,et al.  Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: the Akita-Osaka study. , 2008, Journal of the American College of Cardiology.

[28]  K. Houkin,et al.  Review of past and present research on experimental models of moyamoya disease , 2015 .

[29]  K. Houkin,et al.  Cellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells , 2016, PloS one.

[30]  A. Koizumi,et al.  A new horizon of moyamoya disease and associated health risks explored through RNF213 , 2015, Environmental Health and Preventive Medicine.

[31]  Jing He,et al.  Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation , 2015, Nature Genetics.

[32]  Jingwen,et al.  A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2. , 2014, Human molecular genetics.

[33]  E. Ikeda.  Systemic Vascular Changes in Spontaneous Occlusion of the Circle of Willis , 1991, Stroke.

[34]  E. Sparks,et al.  Genomics and cardiovascular disease. , 2005, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[35]  A. Mukasa,et al.  Genetic Variant RNF213 c.14576G>A in Various Phenotypes of Intracranial Major Artery Stenosis/Occlusion , 2013, Stroke.

[36]  峰晴 陽平.  Autosomal dominant moyamoya disease maps to chromosome 17q25.3 , 2008 .

[37]  K. Tanaka,et al.  Histopathology of the brain vascular network in moyamoya disease. , 1983, Stroke.

[38]  C. Ki,et al.  Frequency of the moyamoya-related RNF213 p.Arg4810Lys variant in 1,516 Korean individuals , 2015, BMC Medical Genetics.

[39]  K. Nozaki,et al.  Histological features of middle cerebral arteries from patients treated for Moyamoya disease. , 2007, Neurologia medico-chirurgica.

[40]  Seung-Chyul Hong,et al.  Coronary Heart Disease in Moyamoya Disease: Are They Concomitant or Coincidence? , 2015, Journal of Korean medical science.

[41]  Hiroyuki Honda,et al.  The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: results from the KING Study. , 2011, Diabetes research and clinical practice.

[42]  K. Kawakami,et al.  Neuromuscular regulation in zebrafish by a large AAA+ ATPase/ubiquitin ligase, mysterin/RNF213 , 2015, Scientific Reports.

[43]  Kohjiro Ueki,et al.  Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus , 2010, Journal of diabetes investigation.

[44]  T. Ogihara,et al.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) , 2009, Hypertension Research.

[45]  H. Izawa,et al.  Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. , 2002 .

[46]  H. Augustin,et al.  Endothelial RSPO3 Controls Vascular Stability and Pruning through Non-canonical WNT/Ca(2+)/NFAT Signaling. , 2016, Developmental cell.

[47]  K. Kosaki,et al.  Homozygosity for moyamoya disease risk allele leads to moyamoya disease with extracranial systemic and pulmonary vasculopathy , 2016, American journal of medical genetics. Part A.

[48]  Y. Hosoda,et al.  Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular Moyamoya disease) , 1997, Clinical Neurology and Neurosurgery.

[49]  Exome sequencing identifies rare LDLR and APOA 5 alleles conferring risk for myocardial infarction , 2016 .

[50]  A. Koizumi,et al.  Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. , 2012, Neurologia medico-chirurgica.

[51]  K. Nakao,et al.  The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality. , 2013, Biochemical and biophysical research communications.

[52]  K. Maeda,et al.  Trends in sudden cardiac death and its risk factors in Japan from 1981 to 2005: the Circulatory Risk in Communities Study (CIRCS) , 2012, BMJ Open.

[53]  K. Sunagawa,et al.  Identification of a Glutamic Acid Repeat Polymorphism of ALMS1 as a Novel Genetic Risk Marker for Early-Onset Myocardial Infarction by Genome-Wide Linkage Analysis , 2013, Circulation. Cardiovascular genetics.